Fleischhacker WW - Search Results

1

Interpreting treatment trials in schizophrenia patients: lessons learned from EUFEST.

Fleischhacker WW, Derks E, Kahn RS. Fleischhacker WW, et al. Schizophr Res. 2012 Jun;138(1):39-40. doi: 10.1016/j.schres.2012.03.027. Epub 2012 Apr 27. Schizophr Res. 2012. PMID: 22542244

2

Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia.

Hofer A, Kemmler G, Eder U, Honeder M, Hummer M, Fleischhacker WW. Hofer A, et al. Among authors: fleischhacker ww. J Clin Psychiatry. 2002 Jan;63(1):49-53. doi: 10.4088/jcp.v63n0110. J Clin Psychiatry. 2002. PMID: 11838626

3

The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia.

Weiss EM, Bilder RM, Fleischhacker WW. Weiss EM, et al. Among authors: fleischhacker ww. Psychopharmacology (Berl). 2002 Jun;162(1):11-7. doi: 10.1007/s00213-002-1053-y. Epub 2002 Apr 17. Psychopharmacology (Berl). 2002. PMID: 12107611 Review.

4

Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe.

Fleischhacker WW, Burns T; European Group For Research In Schizophrenia. Fleischhacker WW, et al. Psychopharmacology (Berl). 2002 Jun;162(1):82-4. doi: 10.1007/s00213-002-1060-z. Epub 2002 Apr 12. Psychopharmacology (Berl). 2002. PMID: 12107622

5

Attitudes of patients with schizophrenia toward placebo-controlled clinical trials.

Hummer M, Holzmeister R, Kemmler G, Eder U, Hofer A, Kurzthaler I, Oehl M, Weiss E, Fleischhacker WW. Hummer M, et al. Among authors: fleischhacker ww. J Clin Psychiatry. 2003 Mar;64(3):277-81. doi: 10.4088/jcp.v64n0308. J Clin Psychiatry. 2003. PMID: 12716268

6

Brain activation patterns during a selective attention test-a functional MRI study in healthy volunteers and patients with schizophrenia.

Weiss EM, Golaszewski S, Mottaghy FM, Hofer A, Hausmann A, Kemmler G, Kremser C, Brinkhoff C, Felber SR, Fleischhacker WW. Weiss EM, et al. Among authors: fleischhacker ww. Psychiatry Res. 2003 May 1;123(1):1-15. doi: 10.1016/s0925-4927(03)00019-2. Psychiatry Res. 2003. PMID: 12738340

7

Placebo or active control trials of antipsychotic drugs?

Fleischhacker WW, Czobor P, Hummer M, Kemmler G, Kohnen R, Volavka J. Fleischhacker WW, et al. Arch Gen Psychiatry. 2003 May;60(5):458-64. doi: 10.1001/archpsyc.60.5.458. Arch Gen Psychiatry. 2003. PMID: 12742866 Review.

8

The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia.

Hofer A, Hummer M, Kemmler G, Kurz M, Kurzthaler I, Fleischhacker WW. Hofer A, et al. Among authors: fleischhacker ww. Int J Neuropsychopharmacol. 2003 Sep;6(3):201-6. doi: 10.1017/S1461145703003456. Int J Neuropsychopharmacol. 2003. PMID: 12974985 Free article.

9

Factors influencing compliance in schizophrenia patients.

Fleischhacker WW, Oehl MA, Hummer M. Fleischhacker WW, et al. J Clin Psychiatry. 2003;64 Suppl 16:10-3. J Clin Psychiatry. 2003. PMID: 14680413

10

Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.

Hofer A, Kemmler G, Eder U, Edlinger M, Hummer M, Fleischhacker WW. Hofer A, et al. Among authors: fleischhacker ww. J Clin Psychiatry. 2004 Jul;65(7):932-9. J Clin Psychiatry. 2004. PMID: 15291682

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters